The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Complement Genes Strongly Predict Recurrence and Graft Outcome in Adult Renal Transplant Recipients with Atypical Hemolytic and Uremic Syndrome
Open accessAbstract
Atypical hemolytic and uremic syndrome (aHUS) is a severe disease strongly associated with genetic abnormalities in the complement alternative pathway. In renal posttransplantation, few data are available on recurrence risk and graft outcome according to genetic background in aHUS patients. The aim of this study was to identify risk factors for recurrence and transplant outcome and, in particular, the role of complement gene abnormalities. We retrospectively studied 57 aHUS patients who had received 71 renal transplants. A mutation in complement gene was identified in 39 (68%), in factor H (CFH), factor I (CFI), membrane cofactor-protein (MCP), C3 and factor B (CFB). At 5 years, death-censored graft survival was 51%. Disease recurrence was associated with graft loss (p = 0.001). Mutations in complement genes were associated with higher risk of recurrence (p = 0.009). Patients with CFH or gain of function (C3, CFB) mutations had a highest risk of recurrence. M-TOR inhibitor was associated with significant risk of recurrence (p = 0.043) but not calcineurin inhibitor immunosuppressive treatment (p = 0.29). Preemptive plasmatherapy was associated with a trend to decrease recurrence (p = 0.07). Our study highlights that characterization of complement genetic abnormalities predicts the risk of recurrence-related graft loss and paves the way for future genetically based individualized prophylactic therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
Moake, J. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020528 · Cited by 1,221
Noris, M., Caprioli, J., Bresin, E., Mossali, C., Pianetti, G., Gamba, S., Daina, E., Fenili, C., Castelletti, F., Sorosina, A., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02210310 · Cited by 1,042
DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1
Ojo, A. O., Wolfe, R. A., Held, P. J., Port, F. K., & Schmouder, R. L. (1997) · Transplantation · doi:10.1097/00007890-199704150-00011 · Cited by 989
Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelletti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., et al. (2006) · Blood · doi:10.1182/blood-2005-10-007252 · Cited by 732
Anti–Factor H Autoantibodies Associated with Atypical Hemolytic Uremic Syndrome
Dragon-Durey, M.-A. G. A., Loirat, C., Cloarec, S., Macher, M.-A., Blouin, J., Nivet, H., Weiss, L., Fridman, W. H., & Frémeaux-Bacchi, V. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004050380 · Cited by 502
Self-citationThrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura
Ruggenenti, P., Noris, M., & Remuzzi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.060003831.x · Cited by 489
Mutations in Complement Factor I Predispose to Development of Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Kemp, E. J., Mayland, E., Winney, R. J., Duffield, J. S., Warwick, G., Richards, A., Ward, R., Goodship, J. A., & Goodship, T. H. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010103 · Cited by 475
de Jorge, E. G., Harris, C. L., Esparza-Gordillo, J., Carreras, L., Arranz, E. A., Garrido, C. A., López-Trascasa, M., Sánchez-Corral, P., Morgan, B. P., & de Córdoba, S. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603420103 · Cited by 447
Richards, A., Kemp, E. J., Liszewski, M. K., Goodship, J. A., Lampe, A. K., Decorte, R., Müslümanogğlu, M. H., Kavukcu, S., Filler, G., Pirson, Y., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135497100 · Cited by 405
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome
Frémeaux-Bacchi, V., Miller, E. C., Liszewski, M. K., Strain, L., Blouin, J., Brown, A. L., Moghal, N., Kaplan, B. S., Weiss, R. A., Lhotta, K., et al. (2008) · Blood · doi:10.1182/blood-2008-01-133702 · Cited by 372
Self-citationFactor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency
Józsi, M., Licht, C., Strobel, S., Zipfel, S. L. H., Richter, H., Heinen, S., Zipfel, P. F., & Skerka, C. (2008) · Blood · doi:10.1182/blood-2007-09-109876 · Cited by 354
Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome
Fremeaux-Bacchi, V, Dragon-Durey, M.-A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E., & Fridman, W. H. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019083 · Cited by 339
Self-citationCaprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
Pickering, M. C., de Jorge, E. G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K. L., Moss, J., Walport, M. J., Cook, H. T., de Córdoba, S. R., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070301 · Cited by 278
Verhoef, G., Johnsen, H. E., Rossi, F. G., Salar, A., Hamilton, L., Schoonen, W. M., Pujol, B., & Duhrsen, U. (2008) · Blood · doi:10.1182/blood.v112.11.4948.4948 · Cited by 233
Zhao, J., Wu, H., Khosravi, M., Cui, H., Qian, X., Kelly, J. A., Kaufman, K. M., Langefeld, C. D., Williams, A. H., Comeau, M. E., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002079 · Cited by 231
Heurich, M., Martínez-Barricarte, R., Francis, N. J., Roberts, D. L., Rodríguez de Córdoba, S., Morgan, B. P., & Harris, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019338108 · Cited by 231
Fremeaux-Bacchi, V. A. A., Moulton, E. A., Kavanagh, D., Dragon-Durey, M.-A. G. A., Blouin, J., Caudy, A., Arzouk, N., Cleper, R., Francois, M., Guest, G., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101051 · Cited by 229
Self-citationThrombotic microangiopathy after renal transplantation in the United States
Reynolds, J. C., Agodoa, L. Y., Yuan, C. M., & Abbott, K. C. (2003) · American Journal of Kidney Diseases · doi:10.1016/j.ajkd.2003.07.008 · Cited by 219
Complement Mutation-Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation
Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., Fakhouri, F., Provost, F., Fridman, W. H., Thervet, E., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02297.x · Cited by 203
Self-citationNew insights into postrenal transplant hemolytic uremic syndrome
Zuber, J., Le Quintrec, M., Sberro-Soussan, R., Loirat, C., Frémeaux-Bacchi, V., & Legendre, C. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.155 · Cited by 196
Self-citationAtypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
Venables, J. P., Strain, L., Routledge, D., Bourn, D., Powell, H. M., Warwicker, P., Diaz-Torres, M. L., Sampson, A., Mead, P., Webb, M., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030431 · Cited by 195
Bienaime, F., Dragon-Durey, M.-A., Regnier, C. H., Nilsson, S. C., Kwan, W. H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.-A., Loirat, C., et al. (2010) · Kidney International · doi:10.1038/ki.2009.472 · Cited by 192
Self-citationFremeaux-Bacchi, V, Kemp, E. J., Goodship, J. A., Dragon-Durey, M.-A., Strain, L., Loirat, C., Deng, H.-W., & Goodship, T. H. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030783 · Cited by 171
Self-citationLiver-Kidney Transplantation to Cure Atypical Hemolytic Uremic Syndrome
Saland, J. M., Ruggenenti, P., & Remuzzi, G. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008080906 · Cited by 165
Roumenina, L. T., Jablonski, M., Hue, C., et al. (2009) · Blood · doi:10.1182/blood-2009-01-197640 · Cited by 157
Self-citationAlternative complement pathway assessment in patients with atypical HUS
Roumenina, L. T., Loirat, C., Dragon‐Durey, M., Halbwachs‐Mecarelli, L., Sautès‐Fridman, C., & Frémeaux‐Bacchi, V. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2010.12.020 · Cited by 157
Self-citationSartelet, H., Toupance, O., Lorenzato, M., Fadel, F., Noël, L. H., Lagonotte, E., Birembaut, P. L., Chanard, J., & Rieu, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01047.x · Cited by 151
Richards, A., Liszewski, M. K., Kavanagh, D., Fang, C. J., Moulton, E. A., Frémeaux‐Bacchi, V., Remuzzi, G., Noris, M., Goodship, T. H. J., & Atkinson, J. P. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.07.004 · Cited by 131
Self-citationCyclosporine and tacrolimus–associated thrombotic microangiopathy
Pham, P. T., Peng, A., Wilkinson, A. H., et al. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.17690 · Cited by 111
Plasmatherapy in Atypical Hemolytic Uremic Syndrome
Loirat, C., Garnier, A., Leclerc, A.-L. S., et al. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1262890 · Cited by 102
Self-citationAtypical Hemolytic Uremic Syndrome Associated with Mutations in Complement Regulator Genes
Quintrec, M. L., Roumenina, L. T., Noris, M., & Frémeaux‐Bacchi, V. (2010) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1262886 · Cited by 43
Self-citationErmini, L., Goodship, T. H. J., Strain, L., Weale, M. E., Sacks, S. H., Cordell, H. J., Frémeaux‐Bacchi, V., & Sheerin, N. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.11.003 · Cited by 41
Self-citationGraft-derived complement as a mediator of transplant injury
Zhou, W., Medof, M. E., Heeger, P. S., & Sacks, S. H. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.007 · Cited by 40
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Self-citationChadban, S. J., Ahn, C., Axelrod, D. A., Foster, B. J., Kasiske, B. L., Kher, V., Kumar, D., Oberbauer, R., Pascual, J., Pilmore, H. L., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003136 · Cited by 738
Connelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
International, F. H., Loirat, C., Fakhouri, F., Ariceta, G., Besbas, N., Bitzan, M., Bjerre, A., Coppo, R., Emma, F., Johnson, S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-015-3076-8 · Cited by 596
Self-citation
Metadata
- Authors
- Le Quintrec, M., Zuber, J., Moulin, B., Kamar, N., Jablonski, M., Lionet, A., Chatelet, V., Mousson, C., Mourad, G., Bridoux, F., Cassuto, E., Loirat, C., Rondeau, E., Delahousse, M., & Frémeaux-Bacchi, V.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 13
- Issue
- 3
- Pages
- 663-675
- ISSN
- 1600-6135 (ISSN-L)
- OpenAlex
- W2166637331
- Cited by
- 268
- References
- 35
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.